BMC Medical Co. Ltd. A Asset Resilience Ratio
BMC Medical Co. Ltd. A asset resilience ratio. BMC Medical Co. Ltd. A (301367) has an Asset Resilience Ratio of 44.96% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BMC Medical Co. Ltd. A (301367) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of BMC Medical Co. Ltd. A (2020–2025)
Asset resilience ratio of BMC Medical Co. Ltd. A from 2020 to 2025. This chart shows how BMC Medical Co. Ltd. A's Asset Resilience Ratio has changed over time. Read 301367 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down BMC Medical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BMC Medical Co. Ltd. A total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.61 Billion | 44.96% |
| Total Liquid Assets | CN¥1.61 Billion | 44.96% |
Asset Resilience Insights
- Very High Liquidity: BMC Medical Co. Ltd. A maintains exceptional liquid asset reserves at 44.96% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BMC Medical Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare BMC Medical Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
BMC Medical Co. Ltd. A Asset Resilience Ratio by Year (2020–2025)
BMC Medical Co. Ltd. A asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for BMC Medical Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 44.76% | CN¥1.52 Billion ≈ $221.73 Million |
CN¥3.38 Billion ≈ $495.33 Million |
-21.97pp |
| 2024-12-31 | 66.74% | CN¥2.29 Billion ≈ $334.47 Million |
CN¥3.42 Billion ≈ $501.16 Million |
+4.64pp |
| 2023-12-31 | 62.10% | CN¥1.81 Billion ≈ $265.22 Million |
CN¥2.92 Billion ≈ $427.07 Million |
-11.70pp |
| 2022-12-31 | 73.80% | CN¥2.16 Billion ≈ $316.08 Million |
CN¥2.93 Billion ≈ $428.28 Million |
+26.50pp |
| 2021-12-31 | 47.30% | CN¥295.00 Million ≈ $43.17 Million |
CN¥623.69 Million ≈ $91.27 Million |
+20.78pp |
| 2020-12-31 | 26.52% | CN¥124.00 Million ≈ $18.15 Million |
CN¥467.64 Million ≈ $68.43 Million |
-- |
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China and internationally. The company offers home-use non-invasive ventilators, ventilation masks, sleep monitors, high-flow humidified oxygen therapy devices, and oxygen concentrators. It also provides chronic disease management services for respiratory h… Read more